Zao Ranbaxy, Russia Sustainability Profile
Zao Ranbaxy, a prominent player in the pharmaceutical industry, is headquartered in Russia (RU) and operates extensively across various regions. Founded in 1993, the company has established itself as a key provider of generic and branded medications, focusing on therapeutic areas such as cardiovascular, anti-infective, and gastrointestinal health. With a commitment to quality and innovation, Zao Ranbaxy offers a diverse portfolio of products that cater to the evolving needs of healthcare professionals and patients alike. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence. Renowned for its rigorous quality standards and competitive pricing, Zao Ranbaxy continues to strengthen its position in the pharmaceutical landscape, contributing to improved health outcomes across Russia and beyond.
DitchCarbon Score
How does Zao Ranbaxy, Russia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zao Ranbaxy, Russia's score of 44 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zao Ranbaxy, based in Russia, currently does not report specific carbon emissions data, as indicated by the absence of available figures. The company is a current subsidiary of Sun Pharmaceutical Industries Limited, which may influence its climate strategies and reporting practices. As of now, Zao Ranbaxy has not established any documented reduction targets or climate pledges. This lack of specific commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given its affiliation with Sun Pharmaceutical Industries Limited, emissions data and climate initiatives may be cascaded from this parent company. However, no specific emissions figures or reduction targets from Sun Pharmaceutical Industries Limited have been provided for Zao Ranbaxy at this time. In summary, Zao Ranbaxy's current climate commitments and emissions data remain unspecified, reflecting a potential area for future development in sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 77,616,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 377,728,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is Zao Ranbaxy, Russia's Industry?
How Carbon Intensive is Zao Ranbaxy, Russia's Location?
Zao Ranbaxy, Russia's Scope 3 Categories Breakdown
Zao Ranbaxy, Russia's Scope 3 emissions, which increased by 6% last year and increased by approximately 6% since 2023, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 51% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 62% of Scope 3 emissions.
Top Scope 3 Categories
Zao Ranbaxy, Russia's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zao Ranbaxy, Russia has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
